PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitors
PTEN (phosphatase and tensin homolog) loss of function is the most common genetic
aberration in endometrioid endometrial carcinomas. In addition to its well-described role in cell …
aberration in endometrioid endometrial carcinomas. In addition to its well-described role in cell …
Emerging therapeutic targets in endometrial cancer
KJ Dedes, D Wetterskog, A Ashworth… - Nature reviews Clinical …, 2011 - nature.com
Endometrial cancer comprises a heterogeneous group of tumors, with distinct risk factors,
clinical presentation, histopathological features and molecular characteristics. Currently, …
clinical presentation, histopathological features and molecular characteristics. Currently, …
Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer …
…, W Polkowski, KJ Dedes, M Niewald, J Blohmer… - bmj, 2020 - bmj.com
Objective To determine whether risk adapted intraoperative radiotherapy, delivered as a
single dose during lumpectomy, can effectively replace postoperative whole breast external …
single dose during lumpectomy, can effectively replace postoperative whole breast external …
Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations
KJ Dedes, PM Wilkerson, D Wetterskog, B Weigelt… - Cell cycle, 2011 - Taylor & Francis
Utilizing the concept of synthetic lethality has provided new opportunities for the development
of targeted therapies, by allowing the targeting of loss of function genetic aberrations. In …
of targeted therapies, by allowing the targeting of loss of function genetic aberrations. In …
[HTML][HTML] ARID1A Mutations and PI3K/AKT Pathway Alterations in Endometriosis and Endometriosis-Associated Ovarian Carcinomas
EP Samartzis, A Noske, KJ Dedes, D Fink… - International journal of …, 2013 - mdpi.com
Endometriosis is a common gynecological disease affecting 6%–10% of women of reproductive
age and is characterized by the presence of endometrial-like tissue in localizations …
age and is characterized by the presence of endometrial-like tissue in localizations …
Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancer
KJ Dedes, R Natrajan, MB Lambros, FC Geyer… - European journal of …, 2011 - Elsevier
Down-regulation of Drosha and Dicer has been suggested to be of prognostic value in some
cancers. The aims of our study were to investigate the down-regulation of Drosha and Dicer …
cancers. The aims of our study were to investigate the down-regulation of Drosha and Dicer …
[HTML][HTML] Loss of ARID1A expression sensitizes cancer cells to PI3K-and AKT-inhibition
EP Samartzis, K Gutsche, KJ Dedes, D Fink, M Stucki… - Oncotarget, 2014 - ncbi.nlm.nih.gov
ARID1A mutations are observed in various tumors, including ovarian clear cell (OCCC) and
endometrioid carcinomas, endometrial, and breast carcinomas. They commonly result in …
endometrioid carcinomas, endometrial, and breast carcinomas. They commonly result in …
Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer
Background. A 58-year-old woman presented with metastatic endometrioid endometrial
adenocarcinoma after being previously treated with surgery and adjuvant radiotherapy for early-…
adenocarcinoma after being previously treated with surgery and adjuvant radiotherapy for early-…
Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast
…, EP Samartzis, KJ Dedes, J Frankum… - The Journal of …, 2014 - Wiley Online Library
Micropapillary carcinoma ( MPC ) is a rare histological special type of breast cancer, characterized
by an aggressive clinical behaviour and a pattern of copy number aberrations ( CNAs …
by an aggressive clinical behaviour and a pattern of copy number aberrations ( CNAs …
Effect of delayed targeted intraoperative radiotherapy vs whole-breast radiotherapy on local recurrence and survival: long-term results from the TARGIT-A randomized …
…, W Polkowski, KJ Dedes, M Niewald, J Blohmer… - JAMA …, 2020 - jamanetwork.com
Importance Conventional adjuvant radiotherapy for breast cancer given daily for several
weeks is onerous and expensive. Some patients may be obliged to choose a mastectomy …
weeks is onerous and expensive. Some patients may be obliged to choose a mastectomy …